InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Conley Sheryl l, Director. Insider active across 4 companies, notably Surgalign Holdings, INC.. Cumulatively, 17 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €71k. History available since 7 May 2021. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Conley Sheryl l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
10,402 sharesCommon StockSEC:0001193125-26-279535:0
30,000 shares0Common StockSEC:0001238659-26-000002:0
7,326 shares0Common StockSEC:0001193125-25-246922:0
14,164 shares0Common StockSEC:0001171843-25-004064:0
30,000 sharesCommon StockSEC:0000950170-25-077827:0
44,444 shares@ US$2.2540.3% of flowCommon StockSEC:0000950170-25-017198:0
5,771 shares0Common StockSEC:0001171843-24-003904:0
25,000 sharesCommon StockSEC:0000950170-24-069573:0
6,500 shares0Common StockSEC:0001171843-23-003957:0
36,364 sharesCommon StockSEC:0001062993-23-012472:0
22,857 shares0Common StockSEC:0001209191-22-046161:0
7,954 shares0Common StockSEC:0001171843-22-004298:0
38,910 sharesCommon StockSEC:0001062993-22-013870:0
8,179 shares0Common StockSEC:0001171843-21-007368:0
6,200 shares@ US$14.03342.5% of flowCommon StockSEC:0001062993-21-005379:0
7,137 sharesCommon StockSEC:0001062993-21-005246:0
57,803 shares0Common StockSEC:0001209191-21-031353:0
17 of 17 declarations
About Conley Sheryl l
CONLEY SHERYL L is Administrateur at Neuronetics, Inc., Anika Therapeutics, Inc. and Surgalign Holdings, INC. She has filed 17 filings in total, and among the sampled recent filings the reported volumes are 0 in purchases and 71212 in sales, covering the period from 2021-05-10 to 2026-06-23. The recent filings include an Attribution transaction at Neuronetics, Inc. on 2025-02-10 and a sale at Neuronetics, Inc. on 2021-06-03.
